N-(2-(4-chlorophenyl)-3-(4-(7-methyl-5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4-yl)piperazin-1-yl)but-3-en-1-yl)cyclopentanamine

ID: ALA4756067

PubChem CID: 162655678

Max Phase: Preclinical

Molecular Formula: C28H35ClN6OS

Molecular Weight: 539.15

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCc2c(sc3ncnc(N4CCN(C(=O)C(CNC5CCCC5)c5ccc(Cl)cc5)CC4)c23)C1

Standard InChI:  InChI=1S/C28H35ClN6OS/c1-33-11-10-22-24(17-33)37-27-25(22)26(31-18-32-27)34-12-14-35(15-13-34)28(36)23(16-30-21-4-2-3-5-21)19-6-8-20(29)9-7-19/h6-9,18,21,23,30H,2-5,10-17H2,1H3

Standard InChI Key:  MDVWQYHBDPRCDG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
   25.2723  -14.5213    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.2723  -15.3467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6982  -14.5213    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9853  -14.1065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6982  -15.3467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9871  -15.7615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1591  -16.5649    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   27.3071  -15.8964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9751  -16.6465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4548  -17.3050    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.2707  -17.2187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6045  -16.4641    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.1186  -15.8088    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4533  -15.0572    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.2749  -14.9696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6060  -14.2178    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1193  -13.5486    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.2976  -13.6362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9625  -14.3931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4569  -12.7939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2778  -12.7075    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.9696  -12.1257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3073  -11.3711    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1523  -12.2111    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6695  -11.5411    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.8494  -11.6313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5110  -12.3824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0030  -13.0525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8213  -12.9632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1282  -11.2847    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.4616  -10.5300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5558  -14.1128    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6903  -12.4741    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   31.2669  -10.3532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.3509   -9.5324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5963   -9.1988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0460   -9.8136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  6  1  0
  5  3  1  0
  3  4  1  0
  5  6  2  0
  6  7  1  0
  7  9  1  0
  8  5  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 14 15  1  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 13 14  1  0
 17 20  1  0
 20 21  2  0
 20 22  1  0
 22 23  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 24  1  0
 22 24  1  0
 23 30  1  0
 30 31  1  0
  1 32  1  0
 27 33  1  0
 31 34  1  0
 34 35  1  0
 35 36  1  0
 36 37  1  0
 37 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4756067

    ---

Associated Targets(Human)

PRKACA Tchem cAMP-dependent protein kinase alpha-catalytic subunit (3475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT2 Tchem Serine/threonine-protein kinase AKT2 (4301 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT3 Tchem Serine/threonine-protein kinase AKT3 (3157 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 539.15Molecular Weight (Monoisotopic): 538.2282AlogP: 4.30#Rotatable Bonds: 6
Polar Surface Area: 64.60Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.70CX LogP: 4.56CX LogD: 2.27
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.50Np Likeness Score: -1.63

References

1. Yu M,Zeng M,Pan Z,Wu F,Guo L,He G.  (2020)  Discovery of novel akt1 inhibitor induces autophagy associated death in hepatocellular carcinoma cells.,  189  [PMID:32007668] [10.1016/j.ejmech.2020.112076]

Source